Search

everythinglearnresearchcommunity

for

Search:↓

A man got a rare rash from the drug topiramate, which went away after he stopped taking it.

Two different mutations in the vitamin D receptor gene cause different symptoms and responses to treatment in Lebanese patients with hereditary rickets.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Smoking is linked to more hair loss and premature graying compared to nonsmokers.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Selenium might help with insulin resistance and cholesterol in PCOS, but more research is needed to confirm its benefits.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

A specific thyroid hormone resistance mutation may be linked to different types of hair loss.

Manage women's cholesterol with diet, exercise, and careful treatment choices, especially during pregnancy, PCOS, and menopause.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

Doctors need to be better prepared to assess and treat obesity in patients.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

Genetics, stress, and health issues can cause early hair greying, which affects self-esteem, and there's no cure, only hair dye.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Platelet-rich plasma may not be very effective for bone healing and hair growth due to a substance it contains that blocks these processes.

DHT may increase the risk of heart disease and death in elderly men.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Most patients with acquired hypoparathyroidism after neck surgery had hair, nail, and skin issues.

Some people have genetic mutations that make them resistant to vitamin D, leading to rickets even with enough vitamin D intake.

People with hypothyroidism and hair loss often have more hair and scalp issues than those without thyroid problems.

Premature graying of hair may suggest health issues and currently lacks effective treatments.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Low-dose oral minoxidil might help with hair loss during chemotherapy, but more research is needed.

The statement offers guidance for hormone therapy and surgery to help gender-incongruent adults affirm a male identity.

Western diet may cause male pattern baldness; low glycemic diet with magnesium could help.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.